European Parliament to Debate No-Confidence Vote
(MENAFN) A no-confidence initiative targeting European Commission President Ursula von der Leyen is scheduled to be discussed on July 7 and voted upon on July 10 during the European Parliament’s full assembly in France, according to a statement posted Thursday on X by a Member of the European Parliament (MEP).
The motion received approval from the Conference of Presidents (COP) after garnering 79 endorsements.
"The motion of No - Confidence against Ursula v d Leyen just gone through the filter of COP (Conference of Presidents). There are 79 signatures. Will be debated next Monday and voted next Thursday in Strasbourg," posted Romanian MEP Gheorghe Piperea, the lawmaker who initiated the proposal.
The effort originates from allegations that von der Leyen breached EU openness regulations by declining to make public the text messages she exchanged with Pfizer CEO Albert Bourla during the 2021 coronavirus vaccine negotiations.
Although the European Court of Justice ruled in favor of a journalist seeking access to the communication, the Commission has not made the content available.
In a conversation with a news agency, Piperea accused the Commission of “hypocrisy,” asserting that it imposes rigid rule-of-law requirements on Eastern European countries while avoiding similar levels of accountability itself.
Though the motion is unlikely to receive sufficient support from a majority of MEPs, Piperea insisted that it conveys a potent symbolic gesture.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
